(NASDAQ:SRTA) NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Strata Critical Medical, Inc. (Nasdaq: SRTA, “Strata” or the “Company”), formerly known as Blade Air Mobility, Inc. (Nasdaq: BLDE), today announced the successful closing of the previously announced divestiture of the Company's Passenger business to Joby Aviation, Inc. (NYSE: JOBY). Joby has elected to pay the up-front consideration in stock. The Company may receive up to an additional $35.0 million in consideration based on maintaining certain employee retention and financial performance targets during the 18 and 12 months, respectively, following today’s closing, as well as the release of up to $10.0 million in indemnity holdbacks, payable in cash or stock at Joby’s election.
Related Questions
How will the divestiture of the passenger business to Joby Aviation affect Strata Critical Medical’s financial outlook and valuation?
What are the potential upside and downside scenarios associated with the up‑front stock consideration, the $35 million performance earn‑out, and the $10 million indemnity holdbacks?
How might the rebranding to Strata Critical Medical and the new SRTA ticker influence investor demand, liquidity, and comparative position within the medical device sector?